Analyzing partially missing confounder information in comparative effectiveness and safety research of therapeutics.

Pharmacoepidemiology and Drug Safety
Sengwee TohMiguel A Hernán

Abstract

Electronic healthcare databases are commonly used in comparative effectiveness and safety research of therapeutics. Many databases now include additional confounder information in a subset of the study population through data linkage or data collection. We described and compared existing methods for analyzing such datasets. Using data from The Health Improvement Network and the relation between non-steroidal anti-inflammatory drugs and upper gastrointestinal bleeding as an example, we employed several methods to handle partially missing confounder information. The crude odds ratio (OR) of upper gastrointestinal bleeding was 1.50 (95% confidence interval: 0.98, 2.28) among selective cyclo-oxygenase-2 inhibitor initiators (n = 43 569) compared with traditional non-steroidal anti-inflammatory drug initiators (n = 411 616). The OR dropped to 0.81 (0.52, 1.27) upon adjustment for confounders recorded for all patients. When further considering three additional variables missing in 22% of the study population (smoking, alcohol consumption, body mass index), the OR was between 0.80 and 0.83 for the missing-category approach, the missing-indicator approach, single imputation by the most common category, multiple imputation by chained eq...Continue Reading

References

Sep 1, 1990·American Journal of Epidemiology·J M PiperE Mitchel
Dec 15, 1995·American Journal of Epidemiology·S Greenland, W D Finkle
Feb 12, 1998·Annals of Internal Medicine·L A Lillard, M M Farmer
Apr 16, 1999·Statistics in Medicine·S van BuurenD L Knook
Nov 5, 1999·Medical Care·B N DoebbelingC F Lynch
Jan 26, 2002·Journal of Clinical Epidemiology·Peter D FarisUNKNOWN APPROACH Investigators. Alberta Provincial Program for Outcome Assessment in Coronary Heart Disease
May 3, 2005·Journal of Clinical Epidemiology·Sebastian Schneeweiss, Jerry Avorn
Jul 1, 2005·American Journal of Epidemiology·Til StürmerRobert J Glynn
May 20, 2006·International Journal of Epidemiology·Stephen R ColeSander Greenland
Jun 23, 2006·Journal of Epidemiology and Community Health·Miguel A Hernán, James M Robins
Sep 19, 2006·Journal of Clinical Epidemiology·Karel G M MoonsFrank E Harrell
Oct 27, 2006·Pharmacoepidemiology and Drug Safety·James D LewisBrian L Strom
Jan 30, 2007·Gastroenterology·Luis A García Rodríguez, Laura Barreales Tolosa
Mar 31, 2007·American Journal of Epidemiology·Til StürmerRobert J Glynn
Jun 9, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Alaa RostomGeorge W Wells
Jul 21, 2007·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Cathy J BradleyBeth A Virnig
Nov 27, 2007·Nature Clinical Practice. Rheumatology·Samy Suissa, Edeltraut Garbe
May 26, 2009·American Heart Journal·Bradley G HammillLesley H Curtis
Jan 1, 2008·The International Journal of Biostatistics·Sengwee Toh, Miguel A Hernán
Mar 23, 2010·Pharmacoepidemiology and Drug Safety·Louise MarstonIrene Petersen
Feb 25, 2011·International Urogynecology Journal·Caroline Tarazi Valeton, Vivian Ferreira do Amaral
Oct 18, 2011·Maternal and Child Health Journal·Susan E AndradePamela E Scott

❮ Previous
Next ❯

Citations

Jun 19, 2015·Current Epidemiology Reports·Michele Jonsson Funk, Suzanne N Landi
Nov 13, 2015·Annals of Epidemiology·Rolf H H GroenwoldOlaf H Klungel
May 11, 2012·Pharmacoepidemiology and Drug Safety·Sebastian SchneeweissScott R Smith
Mar 19, 2014·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·William A MarstonRobert S Kirsner
Jan 23, 2015·Journal of Thrombosis and Haemostasis : JTH·P García-PozaL A García-Rodríguez
Jan 7, 2015·Heart·Francisco J de AbajoLuis A García-Rodríguez
Aug 29, 2014·Cadernos de saúde pública·Cláudia Medina CoeliMarilia Sá Carvalho
Oct 6, 2017·Journal of Comparative Effectiveness Research·Lucas MallaMike English
May 20, 2017·Journal of the American Heart Association·Francisco J de AbajoMiguel J Gil
Sep 29, 2019·Clinical Pharmacology and Therapeutics·Sara Rodríguez-MartínFrancisco J de Abajo
May 4, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Jessica M FranklinJeremy A Rassen
Oct 19, 2017·Pharmacoepidemiology and Drug Safety·Mollie E WoodHedvig M E Nordeng
Feb 1, 2019·Maternal and Child Health Journal·Erica C JansenRuy López-Ridaura
May 6, 2019·The Journal of Nutrition·Dalia SternRuy López-Ridaura
Nov 6, 2020·The British Journal of Nutrition·Adriana MongeDalia Stern

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The British Journal of General Practice : the Journal of the Royal College of General Practitioners
Luis A García Rodríguez, Ana Ruigómez
© 2021 Meta ULC. All rights reserved